Changes in the levels of neuropeptides and their metabolizing enzymes in the brain regions of nucleus basalis magnocellularis-lesioned rats

Journal of Pharmacological Sciences

Volumn 92, Issue 4, 2003, Pages 400-410

  Yamamoto, Masaru ^a   Chikuma, Toshiyuki ^b   Kato, Takeshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Amyloid peptide 25 35; Cholecystokinin; Ibotenic acid; Peptidase; Somatostatin

Indexed keywords

AMINOPEPTIDASE; AMYLOID BETA PROTEIN; CHOLECYSTOKININ; IBOTENIC ACID; MESSENGER RNA; NEUROPEPTIDE; PROTEINASE; PUROMYCIN; SOMATOSTATIN; SUBTILISIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; ENZYME METABOLISM; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOREACTIVITY; MAGNOCELLULAR NUCLEUS; MALE; NONHUMAN; OLIVARY NUCLEUS; RAT;

EID: 0042695883     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.92.400     Document Type: Article

References (56)

1. Hökfelt T. Neuropeptides in perspective: The last ten years. Neuron. 1991;7:867-879.
2. Matsuoka N, Maeda N, Yamaguchi I, Satoh M. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Res. 1994;642:11-19.
3. Matsuoka N, Yamazaki M, Yamaguchi I. Changes in brain somatostatin in memory-deficient rats: Comparison with cholinergic markers. Neuroscience. 1995;66:617-626.
4. Sebret A, Lena I, Crete D, Matsui T, Roques BP, Dauge V. Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J Neurosci. 1999;19:7230-7237.
5. Lieberman DN, Mody I. Substance P enhances NMDA channel function in hippocampal dentate gyrus granule cells. J Neurophysiol. 1998;80:113-119.
6. Randic M, Hecimovic H, Ryu PD. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones. Neurosci Lett. 1990;117:74-80.
7. Rusin KI, Bleakman D, Chard PS, Randic M, Miller RJ. Tachykinins potentiate N-methyl-D-aspartate responses in acutely isolated neurons from the dorsal horn. J Neurochem. 1993;60:952-960.
8. Rusin KI, Jiang MC, Cerne R, Randic M. Interactions between excitatory amino acids and tachykinins in the rat spinal dorsal horn. Brain Res Bull. 1993;30:329-338.
9. Liu X, Andre D, Puizillout JJ. Substance P post-synaptically potentiates glutamate-induced currents in dorsal vagal neurons. Brain Res. 1998;804:95-104.
10. Davies CA, Morroll DR, Prinja D, Mann DM, Gibbs A. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease. J Neurol Sci. 1990;96:59-73.
11. Mazurek MF, Beal MF. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex. Neurology. 1991;41:716-719.
12. Dournaud P, Cervera-Pierot P, Hirsch E, et al. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: An in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience. 1994;61:755-764.
13. Ang LC, Shul DD. Peptidergic neurons of subcortical white matter in aging and Alzheimer's brain. Brain Res. 1995;674:329-335.
14. Grouselle D, Winsky-Sommerer R, David JP, Delacourte A, Dournaud P, Epelbaum J. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett. 1998;255:21-24.
15. Davis KL, Mohs RC, Marin DB, et al. Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry. 1999;56:981-987.
16. Beal MF, Mazurek MF. Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex. Neurology. 1987;37:1205-1209.
17. Clevens RA, Beal MF. Substance P-like immunoreactivity in brains with pathological features of Parkinson's and Alzheimer's diseases. Brain Res. 1989;486:387-390.
18. Quigley BJ Jr., Kowall NW. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex. Neuroscience. 1991;41:41-60.
19. 26]beta-amyloid 1-40 to toxic and proteinase-resistant fragments. Neuroscience. 2001;104:1003-1011.
20. Takeda K, Nakata K, Chikuma T, Ito T, Kato T. Chemical kindling induced by pentylenetetrazol changes cholecystokinin mRNA and peptide levels in rat frontal cortex. Neurosci Lett. 1997;234:115-118.
21. Yamamoto Y, Li Y-H, Huang K, Ohkubo I, Nishi K. Isolation and characterization of an alanyl aminopeptidase from rat liver cytosol as a puromycin-sensitive enkephalin-degrading aminopeptidase. Biol Chem. 1998;379:711-719.
22. Pierotti A, Dong KW, Glucksman MJ, Orlowski M, Roberts JL. Molecular cloning and primary structure of rat testes metalloendopeptidase EC 3.4.24.15. Biochemistry. 1990;29:10323-10329.
23. Takeda K, Uchiumi F, Takita M, Kato T. A rapid enzyme immunoassay for cholecystokinin octapeptide sulfate. Neurochem Int. 1989;15:55-60.
24. Yajima R, Chikuma T, Kato T. A rapid anterograde axonal transport of carboxypeptidase H in rat sciatic nerves. J Neurochem. 1994;63:997-1002.
25. Yajima R, Chikuma T, Kato T. Highly sensitive high-performance liquid chromatography-fluorimetric assay for carboxypeptidase H activity. J Chromatogr B. 1995;667:333-338.
26. Tozawa K, Arakawa E, Chikuma T, et al. Anterograde axonal transport of peptidylglycine α-amidating monooxygenase in rat sciatic nerves. J Neurochem. 1990;55:745-749.
27. Kato T, Hanaoka K, Ochiai O, et al. Secretion of peptidylglycine α-amidating monooxygenase (PAM) from rat salivary glands. Neurochem Int. 1992;21:153-158.
28. Kato T, Nakano T, Kojima K, Nagatsu T, Sakakibara S. Changes in prolyl endopeptidase during maturation of rat brain and hydrolysis of substance P by the purified enzyme. J Neurochem. 1980;35:527-535.
29. Chikuma T, Matsumoto K, Furukawa A, et al. A fluorometric assay for measuring deamidase (lysosomal protective protein) using high-performance liquid chromatography. Anal Biochem. 1996;233:36-41.
30. Hartree EF. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal Biochem. 1972;48:422-427.
31. Shaughnessy LW, Barone S Jr, Mundy WR, Herr DW, Tilson HA. Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain. Brain Res. 1994;637:15-26.
32. 3H]inositolmonophosphate accumulation in rat fronto-parietal cortex. Neurosci Lett. 1995;193:68-70.
33. Anezaki T, Yanagisawa K, Takahashi H, et al. Remote astrocytic response of prefrontal cortex is caused by the lesions in the nucleus basalis of Meynert, but not in the ventral tegmental area. Brain Res. 1992;574:63-69.
34. Monzon-Mayor M, Alvarez M, Arbelo-Galvan J, et al. Long-term evolution of local, proximal and remote astrocyte responses after diverse nucleus basalis lesioning (an experimental Alzheimer model): GFAP immunocytochemical study. Brain Res. 2000;865:245-258.
35. Jenkins HG, Martin J, Dean MF. Receptor-mediated uptake of beta-glucuronidase into primary astrocytes and C6 glioma cells from rat brain. Brain Res. 1988;462:265-274.
36. Dahms P, Mentlein R. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur J Biochem. 1992;208:145-154.
37. Mentlein R, Dahms P. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J Neurochem. 1994;62:27-36.
38. Mizutani S, Goto K, Tsujimoto M, et al. Possible effects of placental leucine aminopeptidase on the regulation of brain-gut hormones in the fetoplacental unit. Biol Neonate. 1996;69:307-317.
39. Balogh A, Cadel S, Foulon T, et al. Aminopeptidase B: A processing enzyme secreted and associated with the plasma membrane of rat pheochromocytoma (PC12) cells. J Cell Sci. 1998;111:161-169.
40. Mayo W, Kharouby M, Le Moal M, Simon H. Memory disturbances following ibotenic acid injections in the nucleus basalis magnocellularis of the rat. Brain Res. 1988;455:213-222.
41. Connor DJ, Langlais PJ, Thal LJ. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res. 1991;555:84-90.
42. Beninger RJ, Kuhnemann S, Ingles JL, Jhamandas K, Boegman RJ. Mnemonic deficits in the double Y-maze are related to the effects of nucleus basalis injections of ibotenic and quisqualic acid on choline acetyltransferase in the rat amygdala. Brain Res Bull. 1994;35:147-152.
43. Shaughnessy LW, Barone S Jr, Mundy WR, Herr DW, Tilson HA. Comparison of intracranial infusions of colchicine and ibotenic acid as models of neurodegeneration in the basal forebrain. Brain Res. 1994;637:15-26.
44. Giovannelli L, Casamenti F, Scali C, Bartolini L, Pepeu G. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience. 1995;66:781-792.
45. Ge J, Long SK, Kilpatrick IC. Preferential blockade of cholecystokinin-8S-induced increases in aspartate and glutamate levels by the CCK(B) receptor antagonist, L-365,260, in rat brain. Eur J Pharmacol. 1998;345:163-170.
46. Johnston MV, McKinney M, Coyle JT. Neocortical cholinergic innervation: A description of extrinsic and intrinsic components in the rat. Exp Brain Res. 1981;43:159-172.
47. Wang HY, Lee DH, Davis CB, Shank RP. Amyloid peptide Aβ(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J Neurochem. 2000;75:1155-1161.
48. Jhamandas JH, Cho C, Jassar B, Harris K, MacTavish D, Easaw J. Cellular mechanisms for amyloid beta-protein activation of rat cholinergic basal forebrain neurons. J Neurophysiol. 2001;86:1312-1320.
49. Li Y, Xu C, Schubert D. The up-regulation of endosomal-lysosomal components in amyloid beta-resistant cells. J Neurochem. 1999;73:1477-1482.
50. Shishido Y, Furushiro M, Tanabe S, Shibata S, Hashimoto S, Yokokura T. Effects of prolyl endopeptidase inhibitors and neuropeptides on delayed neuronal death in rats. Eur J Pharmacol. 1999;372:135-142.
51. Odaka C, Mizuochi T, Shirasawa T, Morain P, Checler F. Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death. FEBS Lett. 2002;512:163-167.
52. Ichai C, Chevallier N, Delaere P, et al. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease. J Neurochem. 1994;62:645-655.
53. Terwel D, Bothmer J, Wolf E, Meng F, Jolles J. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J Neurol Sci. 1998;161:47-56.
54. Shadiack AM, Sun Y, Zigmond RE. Nerve growth factor anti-serum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons. J Neurosci. 2001;21:363-371.
55. Takeda K, Nakata K, Takahashi S, Chikuma T, Kato T. Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex. Brain Res. 1998;779:320-323.
56. Nie Y, Nakashima M, Brubaker PL, et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats. J Clin Invest. 2000;105:955-965.